Literature DB >> 21611079

Drug dosing in renal disease.

Matthew P Doogue1, Thomas M Polasek.   

Abstract

Renal disease alters the effects of many drugs, particularly when active drug moieties are renally cleared. Drug doses should usually be reduced in renal disease in proportion to the predicted reduction in clearance of the active drug moiety. Patient factors to consider in adjusting drug doses include the degree of renal impairment and patient size. Drug factors to consider in adjusting doses include the fraction of the drug excreted unchanged in urine and the drug's therapeutic index. Estimates of renal function are useful to guide dosing of renally cleared drugs with medium therapeutic indices, but are not precise enough to guide dosing of drugs with narrow therapeutic indices. This article discusses principles of drug dose adjustment in renal disease.

Entities:  

Year:  2011        PMID: 21611079      PMCID: PMC3100283     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN: 0159-8090


  7 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Estimating renal function for drug dosing decisions.

Authors:  Graham Rd Jones
Journal:  Clin Biochem Rev       Date:  2011-05

3.  Methods of Estimating GFR - Different Equations Including CKD-EPI.

Authors:  Christopher M Florkowski; Janice Sc Chew-Harris
Journal:  Clin Biochem Rev       Date:  2011-05

4.  Quantification of lean bodyweight.

Authors:  Sarayut Janmahasatian; Stephen B Duffull; Susan Ash; Leigh C Ward; Nuala M Byrne; Bruce Green
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

6.  Individualized compared with conventional dosing of enoxaparin.

Authors:  M A Barras; S B Duffull; J J Atherton; B Green
Journal:  Clin Pharmacol Ther       Date:  2007-10-10       Impact factor: 6.875

Review 7.  Mechanistic basis of using body size and maturation to predict clearance in humans.

Authors:  Brian J Anderson; Nick H G Holford
Journal:  Drug Metab Pharmacokinet       Date:  2009       Impact factor: 3.614

  7 in total
  23 in total

1.  Estimating renal function for drug dosing decisions.

Authors:  Graham Rd Jones
Journal:  Clin Biochem Rev       Date:  2011-05

2.  Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.

Authors:  Alex Secora; G Caleb Alexander; Shoshana H Ballew; Josef Coresh; Morgan E Grams
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

Review 3.  Incorporating pharmacokinetic data into personalised prescribing for older people: challenges and opportunities.

Authors:  Arduino A Mangoni; Elzbieta A Jarmuzewska
Journal:  Eur Geriatr Med       Date:  2021-01-08       Impact factor: 1.710

4.  Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor.

Authors:  Surya P Ayalasomayajula; Thomas H Langenickel; Pierre Jordaan; Wei Zhou; Priyamvada Chandra; Diego Albrecht; Parasar Pal; Iris Rajman; Gangadhar Sunkara
Journal:  Eur J Clin Pharmacol       Date:  2016-05-26       Impact factor: 2.953

5.  A Population Pharmacokinetic Model for 51Cr EDTA to Estimate Renal Function.

Authors:  Isabelle H S Kuan; Stephen B Duffull; Tracey L Putt; John B W Schollum; Robert J Walker; Daniel F B Wright
Journal:  Clin Pharmacokinet       Date:  2017-06       Impact factor: 6.447

6.  Evaluation of applying drug dose adjustment by physicians in patients with renal impairment.

Authors:  Abdulrahman M Alahdal; Ahmed A Elberry
Journal:  Saudi Pharm J       Date:  2011-12-24       Impact factor: 4.330

Review 7.  Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology.

Authors:  Charlotte I S Barker; Eva Germovsek; Rollo L Hoare; Jodi M Lestner; Joanna Lewis; Joseph F Standing
Journal:  Adv Drug Deliv Rev       Date:  2014-01-17       Impact factor: 15.470

Review 8.  Neurological complications in chronic kidney disease.

Authors:  Ria Arnold; Tushar Issar; Arun V Krishnan; Bruce A Pussell
Journal:  JRSM Cardiovasc Dis       Date:  2016-11-03

9.  Phase 1 Renal Impairment Trial Results Supports Targeted Individualized Dosing of ELX-02 in Patients With Nephropathic Cystinosis.

Authors:  Thomas Haverty; David J Wyatt; Kaela M Porter; Andi Leubitz; Kate Banks; Paul Goodyer; Ming-Yi Hu
Journal:  J Clin Pharmacol       Date:  2021-01-18       Impact factor: 3.126

Review 10.  Estimating glomerular filtration rate in older people.

Authors:  Sabrina Garasto; Sergio Fusco; Francesco Corica; Maria Rosignuolo; Antonio Marino; Alberto Montesanto; Francesco De Rango; Marcello Maggio; Vincenzo Mari; Andrea Corsonello; Fabrizia Lattanzio
Journal:  Biomed Res Int       Date:  2014-03-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.